Vitamin D may play a role in mammary gland development and carcinogenesis (1). Results from our team and others (2-4) suggest that high vitamin D intakes/levels may reduce breast cancer risk and mammographic breast density (MBD), a strong and highly heritable breast cancer risk factor (5). 
Introduction
Vitamin D may play a role in mammary gland development and carcinogenesis (1) . Results from our team and others (2) (3) (4) suggest that high vitamin D intakes/levels may reduce breast cancer risk and mammographic breast density (MBD), a strong and highly heritable breast cancer risk factor (5) . The protective action of vitamin D is mainly mediated through the vitamin D receptor (VDR) present in breast cells (1) . Human mammary cells also express cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1), the enzyme that converts the major circulating form of vitamin D {25-hydroxyvitamin D [25(OH)D]} into biologically active 1,25-dihydroxyvitamin D [1,25(OH)D], the ligand for VDR (6) . Recent data suggest that 25(OH)D may be delivered to and internalized by mammary cells in complex with vitamin D -binding protein (DBP; ref. 7) . To further clarify the role of vitamin D in the etiology of breast cancer, we evaluated the association of 13 targeted single-nucleotide polymorphisms (SNP) in VDR, CYP27B1, and DBP genes with MBD in Caucasian women, including the well-studied VDR FokI, BsmI, ApaI, and TaqI previously found associated with breast cancer risk in some Caucasian studies (2) .
Materials and Methods
Study subjects were premenopausal women who underwent screening mammography between February and December 2001 at the Clinique radiologique Audet (Québec, Canada; see ref. 8 for details). Among the 783 eligible women, 746 provided written informed consent to use their blood samples for assays other than those planned at recruitment (8) . This study was approved by a research ethics committee.
Anthropometric measurements and blood samples were taken at recruitment by a trained nurse. Breast cancer risk factors were documented by telephone interview, and diet was evaluated with a food frequency questionnaire.
MBD was blindly assessed by one reviewer (C.D.) using a computer-assisted method (8) . MBD is the proportion of the breast projection showing tissue density on one randomly selected craniocaudal view for each woman. The within-batch intraclass correlation coefficient and the between-batch coefficient of variation were 0.98% and 4%, respectively. DNA was extracted from buffy coat (n = 741) using the PUREGene DNA extraction kit, and then DNA samples were blindly genotyped for 13 selected SNPs located in VDR, CYP27B1, and DBP genes using various platforms (see Table 1 ). Protocols can be provided upon request. Common SNPs were included in the present study if located in promoter regions or exons or found to be associated with breast cancer risk or its associated risk factors in previous studies (2, 9) . Concordance within or between genotyping platforms was higher than 99%. No obvious deviation from Hardy-Weinberg equilibrium was observed for any of the SNPs (P > 0.03). The linkage disequilibrium strength was evaluated with Lewontin's D ¶ statistic for pair-wise SNPs within each gene, and was 1.00 for those located in promoter region or intron 8 and exon 9 of VDR, CYP27B1, or DBP, and 0.02 to 0.78 otherwise.
Crude and adjusted means of MBD by category of genotypes were estimated using generalized linear models, and statistical differences were evaluated with P for heterogeneity. The associations between the number of copies of the rare allele entered as a continuous variable (0, 1, or 2) and MBD were evaluated by linear regression models (P trend ). Univariate and multivariate haplotype analyses were done based on all SNPs or those in haplotype blocks (region of strong linkage disequilibrium) within gene using the method described by Stram et al. (10) . For these analyses, the most common haplotype was used as the reference category. Assumption of normality of residuals from all analyses was met with untransformed variables. All statistical analyses were carried out using SAS version 9.1 (SAS Institute, Inc.).
Results
We observed no statistically significant association of any of the eight VDR SNPs with MBD (Table 2) . No significant association was found between MBD and polymorphisms located in CYP27B1 and DBP genes (Table 2) . Moreover, we observed no significant association of any haplotypes within VDR, CYP27B1, or DBP genes with MBD (data not shown).
Discussion
Well-studied VDR Fok I:rs10735810, Bsm I:rs1544410, ApaI:rs7975232, and TaqI:rs731236 polymorphisms have been associated with breast cancer risk in some Caucasian populations (2, (11) (12) (13) (14) . 6 Knowing the strong link of MBD with breast cancer risk and because effects of vitamin D are mainly mediated via the VDR gene, we hypothesized that those VDR polymorphisms could be associated with MBD. However, our data suggest no evidence of associations between the above VDR polymorphisms and MBD.
The average frequencies of rare and common homozygote of those VDR polymorphisms are f14% to 27% and 26% to 40%, respectively, in Caucasian populations (2, (11) (12) (13) . 6 At such allele frequencies, the present study had 80% power to detect absolute differences of 6% to 8% in MBD comparing rare to common homozygote carriers (with two-sided a = 0.05). It is estimated that a difference of 1% in MBD is associated with 0.4% to 2.7% difference in breast cancer risk (15) . Assuming that breast cancer risk is totally due to MBD and using odds ratios of 1.33 to 1.34 for rare FokI homozygote women from the same city 6 or from another North American Caucasian population (16), we expected at least 12% difference in MBD, therefore suggesting that our sample size was large enough.
The major strength of this study is the reliability of breast density measurements. Moreover, population stratification is not a major source of concern because our population was composed of 99.7% Caucasian women and more than 87.7% women of French-Canadian descent (17) .
Vitamin D signaling pathway in mammary cells involves regulation of VDR, CYP27B1, and DBP genes (18) . In addition to the above well-studied VDR polymorphisms, other SNPs in this gene (rs11568820, rs7139166, rs4516035, rs2238136) as well as in CYP27B1 (rs703842, rs10877012, rs3782130) and DBP (rs7041, rs4588) genes were investigated, but no statistically significant association was observed with MBD. These polymorphisms were associated with breast cancer risk or its related factors, autoimmune Addison's disease, and diabetes or its related factors, respectively (9, 12, (19) (20) (21) . Recently, lack of significant association was observed between both DBP polymorphisms and breast cancer risk (13) .
In conclusion, we found no evidence that VDR, CYP27B1, and DBP polymorphisms studied here were associated with MBD among Caucasian premenopausal women of French descent.
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